Nesina Tablets Specified Drug-use Survey "Type 2 Diabetes Mellitus: Combination Therapy With Hypoglycemic Drug (Insulin Preparation or Rapid-acting Insulin Secretagogues, Etc)"
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2017
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 30 Jun 2017 Planned number of patients changed from 955 to 965.
- 10 Jun 2017 Biomarkers information updated
- 10 May 2017 Planned number of patients changed from 1000 to 955.